Family Medicine Doctors in Bristol, VT Accepting Medicare
8 Family Medicine doctors found. Showing 1 - 8
 Jeffrey S Wulfman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 74 Munsill Ave, Suite 100, Bristol, VT 05443 Phone: 802-453-5028 Fax: 802-453-6105 |
 Natasha Alexa Withers, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 61 Pine St Ste 400, Bristol, VT 05443 Phone: 802-453-7422 Fax: 802-453-4815 |
Jennifer R Wisdom-behounek, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 61 Pine St Bldg 4, Bristol, VT 05443 Phone: 573-884-7733 |
Brian D. Bates, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 61 Pine St, Bristol, VT 05443 Phone: 802-453-5028 Fax: 802-453-6105 |
William Harrison Porter, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 61 Pine St Bldg 4, Bristol, VT 05443 Phone: 802-453-5028 |
Dr. Charles Edward Clark, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 74 Munsill Ave, Suite 100, Bristol, VT 05443 Phone: 802-453-5028 Fax: 802-453-6105 |
Renee Bratspis, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 74 Munsill Ave Ste 100, Bristol, VT 05443 Phone: 802-453-5028 |
Dr. Marian Ruth Bouchard, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 30 Mountain St, Bristol, VT 05443 Phone: 802-453-4696 Fax: 802-471-0360 |
News Archive
AMRI, Genentech enter research and licensing collaboration
AMRI announced today a research and licensing agreement with Genentech, a member of the Roche Group, for a family of antibacterial compounds discovered from AMRI's proprietary research of its natural products sample collection.
The Weizmann Institute of Science purchases novel Aeon™ 1GHz NMR system from Bruker
The Weizmann Institute of Science in Rehovot, Israel today announced major scientific instrument purchases from Bruker (NASDAQ: BRKR), including a novel Aeon™ 1GHz nuclear magnetic resonance (NMR) system for expanding frontiers in structural biology and intrinsically disordered protein (IDPs) research. Furthermore, the Weizmann Institute is adding an Aeon 600 MHz NMR, a 263 GHz dynamic nuclear polarization (DNP)-NMR system, and a Biospec® 15 Tesla system for preclinical ultra-high field magnetic resonance imaging (MRI). Various NMR and electron paramagnetic resonance (EPR) instrument upgrades round out this major acquisition, instantly propelling the Weizmann Institute to the frontiers of modern magnetic resonance research infrastructure.
Cyclenium Pharma, Haplogen sign agreement to discover novel pharmaceutical candidates
Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the research and development of novel drug candidates based on its proprietary macrocyclic chemistry technology, and Haplogen GmbH, a biotechnology company developing anti-infective drugs, today announced the signing of a research agreement aimed at the discovery of novel pharmaceutical candidates in multiple disease areas.
Data from Boehringer Ingelheim's HCV clinical program accepted for presentation at The Liver Meeting
New data from Boehringer Ingelheim's hepatitis C virus clinical development program have been accepted for presentation at the 64th Annual Meeting of the American Association for the Study of Liver Diseases, also known as The Liver Meeting®, taking place November 1-5 in Washington, D.C.
Bilateral and multiple ‘popping' characterizes upper cervical HVLA
Cavitation during upper cervical high-velocity, low amplitude thrust manipulation is significantly more likely to occur bilaterally than unilaterally, say investigators.
› Verified 8 days ago